RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 60 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $982,000 | +67.0% | 109,460 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $588,000 | +16.7% | 109,460 | 0.0% | 0.00% | – |
| Q1 2016 | $504,000 | -20.0% | 109,460 | -9.7% | 0.00% | -100.0% |
| Q4 2015 | $630,000 | -14.1% | 121,160 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $733,000 | -61.7% | 121,160 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $1,915,000 | +60.8% | 121,300 | +10.7% | 0.00% | +100.0% |
| Q1 2015 | $1,191,000 | +3.3% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,153,000 | +9.7% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,051,000 | -17.0% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,266,000 | +15.3% | 109,600 | -0.2% | 0.00% | 0.0% |
| Q1 2014 | $1,098,000 | -23.1% | 109,837 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $1,427,000 | -11.6% | 109,600 | +1.4% | 0.00% | -50.0% |
| Q3 2013 | $1,615,000 | +159.2% | 108,100 | +62.1% | 0.00% | +100.0% |
| Q2 2013 | $623,000 | – | 66,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
| Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
| WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
| Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
| FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
| Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
| Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |